Study: NCT02288338

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 1 (Lipitor®, Ezetrol®)
Description: After 11days withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg and ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2 (Ezetrol®)
Description: ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2(Lipitor®, Ezetrol®)
Description: After 11days withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg and ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2 (Lipitor®)
Description: After 11day withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3(Lipitor®, Ezetrol®)
Description: atorvastatin calcium 40mg, Lipitor® 40mg and ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3 (Lipitor®)
Description: After 11day withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3 (Ezetrol®)
Description: After 11day withdrawal period, ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4 (Lipitor®)
Description: atorvastatin calcium 40mg, Lipitor® 40mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4(Lipitor®, Ezetrol®)
Description: After 11days withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg and ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4 (Ezetrol®)
Description: After 11day withdrawal period, ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5 (Ezetrol®)
Description: ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5 (Lipitor®)
Description: After 11day withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5 (Lipitor®, Ezetrol®)
Description: After 11days withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg and ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 6(Lipitor®, Ezetrol®)
Description: atorvastatin calcium 40mg, Lipitor® 40mg and ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 6 (Ezetrol®)
Description: After 11days withdrawal period, ezetimibe 10mg, Ezetrol® 10mg will be administered to healthy volunteers during 7days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 6 (Lipitor®)
Description: After 11day withdrawal period, atorvastatin calcium 40mg, Lipitor® 40mg will be administered to healthy volunteers during 7days